INSP — Inspire Medical Systems Inc
NYSE · Healthcare · Medical Devices
$63.44
+$1.92 (+3.12%)
Inspire Medical Systems Inc (INSP) is a medical devices company listed on NYSE. It is led by Timothy P. Herbert, based in 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416, with about 1,333 employees. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Latest reported INSP revenue for 2025-09-30 was $224.5M. Net income was $9.9M. Revenue was up 3.4% from 2025-06-30 to 2025-09-30. INSP currently screens at market cap $1.19B and trailing P/E 9.4.
Use this INSP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INSP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INSP SEC filings page. Lician reads the product cache first so this HTML stays unique to Inspire Medical Systems Inc even when a live quote feed is slow.
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
INSP Key Statistics
Market Cap
$1.19B
Volume
95,423
Previous Close
$61.47
Day Range
$60.38 – $61.89
P/E Ratio
9.36
EPS
$1.75
Revenue
$802.80M
Net Income
$53.51M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+28.5%
Profit Margin
6.7%
Employees
1,333
INSP Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $802.80M | $624.80M | $407.86M | $233.39M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $53.51M | -$21.15M | -$44.88M | -$42.04M |
| EPS (Diluted) | $1.75 | -$0.72 | -$1.60 | -$1.54 |
Total Assets
$808.38M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$150.15M
Operating Cash Flow
$130.25M
Free Cash Flow
$0.00
Inspire Medical Systems Inc Company Information
- Founder, Chairman, CEO & President
- Timothy P. Herbert
- Headquarters
- 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416
- Website
- www.inspiresleep.com
- Phone
- 844 672 4357
- IPO / Founded
- 2018-05-03
- Sector
- Healthcare
- Industry
- Medical Devices